GOWER BOB G 4
4 · Ensysce Biosciences, Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
GOWER BOB G
Director10% Owner
Transactions
- Purchase
Common Stock
2022-12-09$1.40/sh+357,143$500,000→ 753,095 total - Award
Warrants
2022-12-09+714,286→ 716,365 totalExercise: $1.40Exp: 2027-12-09→ Common Stock (714,286 underlying)
Footnotes (3)
- [F1]On October 28, 2022, Ensysce Biosciences, Inc. (the "Company"), pursuant to an amendment to the Company's Third Amended and Restated Certificate of Incorporation, effectuated a one-for-twenty reverse stock split of the Company's common stock, par value $0.0001 (the "Common Stock").
- [F2]On December 9, 2022, Mr. Gower purchased 357,143 shares of Common Stock at a price of $1.40 per share.
- [F3]On December 9, 2022, Mr. Gower purchased 357,143 warrants to purchase 714,286 shares of Common Stock with an exercise price of $1.40 per share (the "Warrants") in an underwritten offering further described on the Company's Prospectus filed pursuant to Rule 424(b)(4) (File No. 333-268038) filed with the Commission on December 9, 2022. The Warrants are immediately exercisable and may be exercised until five years from the date of issuance.